|
|
|
|
When good goes awry: the aggregation of protein therapeutics
|
|
|
|
|
|
|
|
نویسنده
|
redington j.m. ,breydo l. ,uversky v.n.
|
|
منبع
|
protein and peptide letters - 2017 - دوره : 24 - شماره : 4 - صفحه:340 -347
|
|
چکیده
|
Protein therapeutics are playing an increasingly important role in treatment of a variety of human diseases. however,like the rest of proteins,they are susceptible to aggregation. aggregation of proteinaceous pharmaceuticals can cause a loss of efficacy and,potentially,cytotoxicity and an immunogenic response. this review describes various ways protein therapeutics aggregate and a variety of approaches taken to prevent or minimize this process. © 2017 bentham science publishers.
|
|
کلیدواژه
|
Aggregation; Antibodies; Delivery; Formulation; Glucagon; Insulin; Storage
|
|
آدرس
|
department of molecular medicine,morsani college of medicine,university of south florida,tampa,fl, United States, department of molecular medicine,morsani college of medicine,university of south florida,tampa,fl,united states,usf health byrd alzheimer's research institute,morsani college of medicine,university of south florida,tampa,fl, United States, department of molecular medicine,morsani college of medicine,university of south florida,tampa,fl,united states,usf health byrd alzheimer's research institute,morsani college of medicine,university of south florida,tampa,fl,united states,laboratory of structural dynamics,stability and folding of proteins,institute of cytology,russian academy of sciences,st. petersburg, Russian Federation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|